Immuneering Corp (IMRX)

2.00 -0.36 (-15.25%) USD  |  NASDAQ  |  Jan 08, 16:00
1.99 -0.01 (-0.50%) After-Hours: 20:00
More

Immuneering Cash and Short Term Investments (Annual): 85.67M for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for IMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Amicus Therapeutics Inc 286.20M
PTC Therapeutics Inc 876.74M
Aadi Bioscience Inc 108.84M
AN2 Therapeutics Inc 107.30M
NovaBay Pharmaceuticals Inc 3.13M